BD’s Liverty TIPS Stent Graft for Portal Hypertension Launched in the United States

October 28, 2026—BD (Becton, Dickinson and Company) announced the launch of the Liverty transjugular intrahepatic portosystemic shunt (TIPS) stent graft to treat portal hypertension in the United States.

According to the company, its next-generation TIPS system is designed to provide physicians with deployment accuracy and control, as well as the flexibility to tailor treatment based on individual patient anatomy, disease progression, and clinical goals.

The device received CE Mark approval in April 2026 and has been launched in Europe.

BD noted that TIPS procedures for managing conditions such as variceal bleeding and refractory ascites can vary significantly based on patient anatomy, disease progression, and treatment goals.

The Liverty TIPS stent graft is designed to address this variability by enabling a more tailored, patient-specific approach to therapy, stated the company.

As outlined in the press release, the Liverty TIPS stent graft features include an expandable diameter design (6-10 mm) to address patient-specific hemodynamics, a range of covered stent lengths (4-10 cm) to support varied anatomies, and a fully sheathed, triaxial delivery system for deployment accuracy, control, and ease of use. The delivery system allows for sheathless tracking through the liver parenchyma.

The BD press release advised that the Liverty device is supported by 6-month interim results from the prospective, multicenter ARCH clinical study, which was composed of 177 patients and included data for small TIPS diameter (6-7 mm). Ziv Haskal, MD, is Principal Investigator of the ARCH trial.

“I’ve helped develop a lot of existing TIPS technology,” commented Dr. Haskal in BD’s press release. “Device innovation is intended to advance every operator’s daily expertise. What stands out using the Liverty TIPS stent graft is the unique ease of delivering the device into position and controlling it during deployment. The ability to accommodate the new range of intended TIPS diameters and longer lengths will help physicians best tailor treatment to each patient.”